National drug utilization trend of analgesics in China: an analysis of procurement data at 793 public hospitals from 2013 to 2018

References

• Barkin, RL. The pharmacology of topical analgesics. J Postgrad Med. 2013;125(1):7–18.
   Google Scholar
• Institute of Medicine (US) Committee on Advancing Pain Research, Care and Education. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington (DC): National Academies Press (US); 2012.
   Google Scholar
• McCarberg, BH, Nicholson, BD, Todd, KH, Palmer, T, Penles, L. The impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet survey. Am J Ther. 2008;15(4):312–20.
   PubMed Web of Science ®Google Scholar
• Gordon, DB, de Leon-Casasola, OA, Wu, CL, Sluka, KA, Brennan, TJ, Chou, R. Research gaps in practice guidelines for acute postoperative pain management in adults: findings from a review of the evidence for an American Pain Society Clinical Practice Guideline. J Pain. 2016;17(2):158–66.
   PubMed Web of Science ®Google Scholar
• Kaye, AD, Jones, MR, Kaye, AM, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1. J Pain Physician. 2017;20(2S):S93.
   PubMed Web of Science ®Google Scholar
• Gong, XP, Li, J, Wang, C, et al. Analysis of non-opioid analgesics prescriptions for cancer patients in outpatient oncology. China Pharm. 2015;9:111–4 (Chinese).
   Google Scholar
• NHC. Opinions on controlling the unreasonable increase of medical expenses in Public Hospitals. 2015. (Chinese).
   Google Scholar
• The State Council. Opinions on further reforming and perfecting the policy of drug production, circulation and use. 2017. (Chinese).
   Google Scholar
• The State Council. “Thirteenth Five-Year Plan” for deepening the reform of healthcare. 2016. (Chinese).
   Google Scholar
• NHC. National Center for Comprehensive Evaluation of Drug and Health Technology established. 2018. (Chinese).
   Google Scholar
• NHC. Notice on drug use monitoring and clinical comprehensive evaluation. 2019. (Chinese).
   Google Scholar
• Li, R, Zhang, YH. Analysis on the utilization of analgesic drugs in 9 cancer hospitals of China in 2012. Chin J Hosp Pharm. 2012;034(019):1672–5 (Chinese).
   Google Scholar
• Wang JH. Analysis on the utilization of narcotic analgesics in the inpatients of Gansu Provincial Hospital of Maternal and Child Health from 2006 to 2010. Evaluation and analysis of drug-use in hospitals of China. 2011. (Chinese).
   Google Scholar
• Zhi, MJ, Wei, XM, Gao, X, et al. Analysis of the clinical use of opioid analgesics in China. Chin J Pharmacoepidemiol. 2018;27(6):400–5 (Chinese).
   Google Scholar
• Li, XP, Qin, X, Jing, FB, Han, B, Sui, ZG. Analysis of the utilization of opioid analgesic drugs in 29 Hospitals of Qingdao District. J China Pharm. 2016;027(026):3621–3 (Chinese).
   Google Scholar
• Chinese Association of Anesthesiology. Expert consensus on postoperative pain management in adults. J Clin Anesth. 2017. (Chinese).
   Google Scholar
• Leng, X, Wei, J, Liu, L, et al. Expert consensus on perioperative pain management in general surgery. J Chin J Gen Surg. 2015;30:166–73 (Chinese).
   Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2020. Oslo; 2019.
   Google Scholar
• Kevin Bylund. Dezocine. xpharm the comprehensive pharmacology reference. 2007;1–5.
   Google Scholar
• Liu, RY, Huang, XY, Yeliseev, A, Xi, J, Roth, BL. Novel molecular targets of dezocine and their clinical implications. Anesthesiology. 2014;120(3):714–23.
   PubMed Web of Science ®Google Scholar
• Wang, YH, Chai, JR, Xu, XJ, et al. Pharmacological characterization of dezocine, a potent analgesic acting as a κ partial agonist and μ partial agonist. Sci Rep. 2018;8(1):14087.
   PubMedGoogle Scholar
• Ding, Y, White, PF. Comparative effects of ketorolac, dezocine, and fentanyl as adjuvants during outpatient anesthesia. Anesth Analg. 1992;1(1):566–71.
   Google Scholar
• Finucane, BT, Floyd, JB, Petro, DJ. Postoperative pain relief: a double-blind comparison of dezocine, butorphanol, and placebo. South Med J. 2012;79(5):548.
   Google Scholar
• Li, ZS, Dong, H. Research of dezocine in clinical application. Med Recapitul. 2012;18(23):4021–3 (Chinese).
   Google Scholar
• Han, XP, Huang, YL, Sun, ZT, Yang, YJ, Ma, FL. The effects of equivalent dezocine or fentanyl for postoperative analgesia in thyroid patients. J Clin Anesthesiol. 2011;27(10):993–4 (Chinese).
   Google Scholar
• Song, SY, Yue, XQ. Clinical observation of dezocine in preventing restlessness of patients during general anesthesia. J Pract Med. 2012;28(16):2790–1 (Chinese).
   Google Scholar
• Gal, TJ, DiFazio, CA. Ventilatory and analgesic effects of dezocine in humans. Anesthesiology. 1984;61(6):716–22.
   PubMed Web of Science ®Google Scholar
• Romagnoli, A, Keats, AS. Ceiling respiratory depression by dezocine. Clin Pharmacol Ther. 1984;35(3):367–73.
   PubMed Web of Science ®Google Scholar
• Schaffer, AL, Karanges, EA, Buckley, NA, et al. Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: an Australian population-based study. Pharmacoepidemiol Drug Saf. 2019;28(1):97–105.
   PubMed Web of Science ®Google Scholar
• Paulozzi, LJ, Mack, KA, Hockenberry, JM. Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines—United States, 2012. MMWR Morb Mortal Wkly Rep. 2014;63(26):563–8.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. The DAWN report: highlights of the 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. Rockville: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality; 2013.
   Google Scholar
• Edlund, MJ, Martin, BC, Russo, JE, DeVries, A, Braden, JB, Sullivan, MD. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain. 2014;30(7):557–64.
   PubMed Web of Science ®Google Scholar
• Bohnert, AS, Valenstein, M, Bair, MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315–21.
   PubMed Web of Science ®Google Scholar
• Mars, SG, Rosenblum, D, Ciccarone, D. Fentanyl: the many challenges ahead. Addiction. 2019;114(5):785–6.
   PubMed Web of Science ®Google Scholar
• Mounteney, J, Griggiths, P, Sedefov, R, Evans-Brown, M. Fentanils: a serious threat to public health. Addiction. 2019;114(5):783–5.
   PubMed Web of Science ®Google Scholar
• Steven D, Waldman MD. CHAPTER 344-Opioid Analgesics. In: Pain review. 2009. pp. 635–40.
   Google Scholar
• Mathias L, McDonald D, Sargent W, Shoemaker-Hunt S, Losby J. Improving Opioid prescribing through the development and evaluation of Clinical Decision Support tools across four large healthcare systems. APHA’s 2019 annual meeting and expo. 2019. Nov 2–6.
   Google Scholar
• Hill, MV, McMahon, ML, Stucke, RS, Barth, RJJr. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg. 2017;265(4):709–14.
   PubMed Web of Science ®Google Scholar
• Harris, K, Curtis, J, Larsen, B, et al. Opioid pain medication use after dermatologic surgery: a prospective observational study of 212 dermatologic surgery patients. JAMA Dermatol. 2013;149(3):317–21.
   PubMed Web of Science ®Google Scholar
• Barnett, ML, Olenski, AR, Jena, AB. Opioid-prescribing patterns of emergency physicians and risk of long-term use. N Engl J Med. 2017;376(7):663–73.
   PubMed Web of Science ®Google Scholar
• Howard, R, Waljee, J, Brummett, C, Englesbe, M, Lee, J. Reduction in opioid prescribing through evidence-based prescribing guidelines. JAMA Surg. 2018;153(3):285–7.
   PubMed Web of Science ®Google Scholar
• Dowell, D, Haegerich, TM, Chou, R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep. 2016;65(RR-1):1–49.
   PubMed Web of Science ®Google Scholar
• Cross, AJ, Buchbinder, R, Bourne, A, et al. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: protocol for a qualitative evidence synthesis using the Theoretical Domains Framework. BMJ Open. 2019;9(11):e034039.
   PubMed Web of Science ®Google Scholar
• Schatz, AA, Oliver, TK, Swarm, RA, et al. Bridging the gap among clinical practice guidelines for pain management in cancer and sickle cell disease. J Natl Compr Cancer Netw. 2020;18(4):392–9.
   PubMed Web of Science ®Google Scholar
• Leonard, CE, Freeman, CP, Newcomb, CW, et al. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury. Pharmacoepidemiol Drug Saf. 2012;21(11):1155–72.
   PubMed Web of Science ®Google Scholar
• Gooch, K, Culleton, BF, Manns, BJ, et al. NSAID use and progression of chronic kidney disease. Am J Med. 2007;120(3):e281-287.
   PubMed Web of Science ®Google Scholar
• Bhala, N, Emberson, J, Merhi, A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769–79.
   PubMed Web of Science ®Google Scholar
• Zhang, XY, Donnan, PT, Bell, S, Guthrie, B. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol. 2017;18(1):256.
   PubMedGoogle Scholar
• Lipworth, L, Abdel-Kader, K, Morse, J, et al. High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort study. BMC Nephrol. 2016;17(1):189.
   PubMedGoogle Scholar
• Brune, K, Patrignani, P. New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res. 2015;8:105–18.
   PubMed Web of Science ®Google Scholar
• Sharma, M, Gulmez, SE, Lassalle, R, Moore, N. Use of NSAIDs in France: analysis from French reimbursement (CNAM-TS) database. J Pharm Res. 2012;5(9):4893–6.
   Google Scholar
• Inotai, A, Hanko, B, Meszaros, A. Trends in the non-steroidal anti-inflammatory drug market in six Central-Eastern European countries based on retail information. Pharmacoepidemiol Drug Saf. 2010;19(2):183–90.
   PubMed Web of Science ®Google Scholar
• Meagher, EA. Cardiovascular and renovascular implications of COX-2 inhibition. Curr Pharm Des. 2004;10(6):603–11.
   PubMed Web of Science ®Google Scholar
• Nussmeier, NA, Whelton, AA, Brown, MT, et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med. 2005;352(11):1081–91.
   PubMed Web of Science ®Google Scholar
• Bally, M, Dendukuri, N, Rich, B, et al. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ. 2017;357:j1909.
   PubMed Web of Science ®Google Scholar
• Kuffner, EK, Green, JL, Bogdan, GM, et al. The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients—a multicenter randomized study. BMC Med. 2007;5:13.
   PubMed Web of Science ®Google Scholar
• Rimon, G, Sidhu, RS, Lauver, DA, et al. COXIBs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1. Proc Natl Acad Sci USA. 2010;107(1):28–33.
   PubMed Web of Science ®Google Scholar
• Adams, RJ, Appleton, SL, Gill, TK, Taylor, AW, Wilson, DH, Hill, CL. Cause for concern in the use of non-steroidal anti-inflammatory medications in the community-a population-based study. BMC Fam Pract. 2011;12(1):70.
   PubMedGoogle Scholar